Testosterone Completed Phase 4 Trials for Hypogonadism / Diabetes Mellitus (DM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02937740Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natestoâ„¢
NCT00349362Testosterone for Men With Insulin Treated Type 2 Diabetes
NCT01127659Testosterone Replacement in Men With Diabetes and Obesity
NCT01893281The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel
NCT02111473The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism